TY - JOUR
T1 - HIV-1 tat protein suppresses cholangiocyte toll- like receptor 4 expression and defense against cryptosporidium parvum
AU - O'Hara, Steven P.
AU - Small, Aaron J.
AU - Gajdos, Gabriella B.
AU - Badley, Andrew D.
AU - Chen, Xian Ming
AU - LaRusso, Nicholas F.
N1 - Funding Information:
Received 23 May 2008; accepted 22 September 2008; electronically published 5 March 2009. Potential conflicts of interest: none reported. Presented in part: American Society for Cell Biology Conference, Washington, DC, 1–5 December 2007 (abstract 532). Financial support: National Institutes of Health (grants DK57993 to N.F.L., DK76922 to S.P.O., A1062261 to A.D.B., and A2071321 to X.-M.C.); Mayo Foundation. a S.P.O. and A.J.S. contributed equally to this work. Reprints or correspondence: Dr. Nicholas F. LaRusso, Miles and Shirley Fiterman Center for Digestive Diseases, Div. of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN 55905 (larusso.nicholas@mayo.edu).
PY - 2009/4/15
Y1 - 2009/4/15
N2 - Biliary cryptosporidiosis is associated with acquired immunodeficiency syndrome (AIDS) cholangiopathy and occurs almost exclusively in adult patients with AIDS. Infection of biliary epithelial cells (cholangiocytes) with Cryptosporidium parvum induces Toll-like receptor (TLR) 4 expression and stimulates a TLR-dependent response against infection. Here, we tested whether human immunodeficiency virus type 1 (HIV-1) Tat affects TLR expression and, hence, anti-C. parvum defense responses. Using an in vitro model of human biliary cryptosporidiosis, we found that recombinant Tat protein increased TLR4 mRNA expression in both uninfected and C. parvum-infected cholangiocytes. Conversely, Tat decreased TLR4 protein levels and suppressed C. parvum-induced TLR4 protein expression. Using actinomycin to inhibit transcription,wefound that Tat increased the half-life ofTLR4mRNAfrom̃25 to 60 min, and RNA gel-shift assays demonstrated direct binding of Tat to TLR4 mRNA. In vitro transcription/translation studies suggested that Tat does not affect transcription but does decrease TLR4 translation. Importantly, more parasites were foundin Tat-treated cellsthanin control cells48hafter infection. Thesefindingssuggest thatTatinhibits cholangiocyte TLR4proteinexpressionthroughtranslational inhibition. Theseeventsappeartodiminishtheabilityofcholangiocytes to initiate an innate immune response to C. parvum. We suggest that these findings may contribute to the unusual susceptibility of HIV-infected individuals to biliary cryptosporidiosis.
AB - Biliary cryptosporidiosis is associated with acquired immunodeficiency syndrome (AIDS) cholangiopathy and occurs almost exclusively in adult patients with AIDS. Infection of biliary epithelial cells (cholangiocytes) with Cryptosporidium parvum induces Toll-like receptor (TLR) 4 expression and stimulates a TLR-dependent response against infection. Here, we tested whether human immunodeficiency virus type 1 (HIV-1) Tat affects TLR expression and, hence, anti-C. parvum defense responses. Using an in vitro model of human biliary cryptosporidiosis, we found that recombinant Tat protein increased TLR4 mRNA expression in both uninfected and C. parvum-infected cholangiocytes. Conversely, Tat decreased TLR4 protein levels and suppressed C. parvum-induced TLR4 protein expression. Using actinomycin to inhibit transcription,wefound that Tat increased the half-life ofTLR4mRNAfrom̃25 to 60 min, and RNA gel-shift assays demonstrated direct binding of Tat to TLR4 mRNA. In vitro transcription/translation studies suggested that Tat does not affect transcription but does decrease TLR4 translation. Importantly, more parasites were foundin Tat-treated cellsthanin control cells48hafter infection. Thesefindingssuggest thatTatinhibits cholangiocyte TLR4proteinexpressionthroughtranslational inhibition. Theseeventsappeartodiminishtheabilityofcholangiocytes to initiate an innate immune response to C. parvum. We suggest that these findings may contribute to the unusual susceptibility of HIV-infected individuals to biliary cryptosporidiosis.
UR - http://www.scopus.com/inward/record.url?scp=65649149370&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65649149370&partnerID=8YFLogxK
U2 - 10.1086/597387
DO - 10.1086/597387
M3 - Article
C2 - 19265483
AN - SCOPUS:65649149370
SN - 0022-1899
VL - 199
SP - 1195
EP - 1204
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 8
ER -